Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Inspire Medical Systems (INSP) Invested Capital (2017 - 2025)

Historic Invested Capital for Inspire Medical Systems (INSP) over the last 9 years, with Q4 2025 value amounting to $781.2 million.

  • Inspire Medical Systems' Invested Capital rose 1326.17% to $781.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $781.2 million, marking a year-over-year increase of 1326.17%. This contributed to the annual value of $781.2 million for FY2025, which is 1326.17% up from last year.
  • Latest data reveals that Inspire Medical Systems reported Invested Capital of $781.2 million as of Q4 2025, which was up 1326.17% from $666.5 million recorded in Q3 2025.
  • Inspire Medical Systems' 5-year Invested Capital high stood at $781.2 million for Q4 2025, and its period low was $219.9 million during Q2 2021.
  • In the last 5 years, Inspire Medical Systems' Invested Capital had a median value of $536.8 million in 2023 and averaged $491.8 million.
  • As far as peak fluctuations go, Inspire Medical Systems' Invested Capital plummeted by 585.63% in 2021, and later soared by 13321.42% in 2023.
  • Quarter analysis of 5 years shows Inspire Medical Systems' Invested Capital stood at $229.0 million in 2021, then skyrocketed by 116.55% to $496.0 million in 2022, then rose by 15.42% to $572.5 million in 2023, then increased by 20.47% to $689.7 million in 2024, then increased by 13.26% to $781.2 million in 2025.
  • Its Invested Capital stands at $781.2 million for Q4 2025, versus $666.5 million for Q3 2025 and $677.8 million for Q2 2025.